Lifecore Biomedical, Inc. \De\ Q3 FY2022 Earnings Call

Lifecore Biomedical, Inc. \De\ (LFCR)

Earnings Call FY2022 Q3 Call date: 2022-04-05 Concluded

Quarter scorecard

Revenue

$35.23M

+26.7% YoY

Diluted EPS

$-0.46

Gross margin

33.0%

-6.3 pp YoY

Net income

-$13.59M

Switzerland $8.20M

+412.5%

All Other Countries $3.70M

-5.1%

All Other Countries $1.60M

United Kingdom $900,000

-25%

Czechia $700,000

-12.5%

Ireland $500,000

+66.7%

Canada $200,000

-92.6%

Australia $0